A modulator based regulatory network for ERα signaling pathway.

Heng Yi Wu, Pengyue Zheng, Guanglong Jiang, Yunlong Liu, Kenneth P. Nephew, Hui-ming Huang, Lang Li

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Estrogens control multiple functions of hormone-responsive breast cancer cells. They regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. ERα requires distinct co-regulator or modulators for efficient transcriptional regulation, and they form a regulatory network. Knowing this regulatory network will enable systematic study of the effect of ERα on breast cancer. To investigate the regulatory network of ERα and discover novel modulators of ERα functions, we proposed an analytical method based on a linear regression model to identify translational modulators and their network relationships. In the network analysis, a group of specific modulator and target genes were selected according to the functionality of modulator and the ERα binding. Network formed from targets genes with ERα binding was called ERα genomic regulatory network; while network formed from targets genes without ERα binding was called ERα non-genomic regulatory network. Considering the active or repressive function of ERα, active or repressive function of a modulator, and agonist or antagonist effect of a modulator on ERα, the ERα/modulator/target relationships were categorized into 27 classes. Using the gene expression data and ERα Chip-seq data from the MCF-7 cell line, the ERα genomic/non-genomic regulatory networks were built by merging ERα/ modulator/target triplets (TF, M, T), where TF refers to the ERα, M refers to the modulator, and T refers to the target. Comparing these two networks, ERα non-genomic network has lower FDR than the genomic network. In order to validate these two networks, the same network analysis was performed in the gene expression data from the ZR-75.1 cell. The network overlap analysis between two cancer cells showed 1% overlap for the ERα genomic regulatory network, but 4% overlap for the non-genomic regulatory network. We proposed a novel approach to infer the ERα/modulator/target relationships, and construct the genomic/non-genomic regulatory networks in two cancer cells. We found that the non-genomic regulatory network is more reliable than the genomic regulatory network.

Original languageEnglish (US)
Article numberS6
JournalBMC Genomics
Volume13 Suppl 6
StatePublished - 2012
Externally publishedYes

Fingerprint

Breast Neoplasms
Gene Expression
Linear Models
Estrogens
Physiological Phenomena
Genes
Biological Phenomena
MCF-7 Cells
Neoplasms
Hormones
Cell Line

ASJC Scopus subject areas

  • Biotechnology
  • Genetics

Cite this

Wu, H. Y., Zheng, P., Jiang, G., Liu, Y., Nephew, K. P., Huang, H., & Li, L. (2012). A modulator based regulatory network for ERα signaling pathway. BMC Genomics, 13 Suppl 6, [S6].

A modulator based regulatory network for ERα signaling pathway. / Wu, Heng Yi; Zheng, Pengyue; Jiang, Guanglong; Liu, Yunlong; Nephew, Kenneth P.; Huang, Hui-ming; Li, Lang.

In: BMC Genomics, Vol. 13 Suppl 6, S6, 2012.

Research output: Contribution to journalArticle

Wu, HY, Zheng, P, Jiang, G, Liu, Y, Nephew, KP, Huang, H & Li, L 2012, 'A modulator based regulatory network for ERα signaling pathway.', BMC Genomics, vol. 13 Suppl 6, S6.
Wu HY, Zheng P, Jiang G, Liu Y, Nephew KP, Huang H et al. A modulator based regulatory network for ERα signaling pathway. BMC Genomics. 2012;13 Suppl 6. S6.
Wu, Heng Yi ; Zheng, Pengyue ; Jiang, Guanglong ; Liu, Yunlong ; Nephew, Kenneth P. ; Huang, Hui-ming ; Li, Lang. / A modulator based regulatory network for ERα signaling pathway. In: BMC Genomics. 2012 ; Vol. 13 Suppl 6.
@article{0e20693c81694207bb026f0896d45330,
title = "A modulator based regulatory network for ERα signaling pathway.",
abstract = "Estrogens control multiple functions of hormone-responsive breast cancer cells. They regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. ERα requires distinct co-regulator or modulators for efficient transcriptional regulation, and they form a regulatory network. Knowing this regulatory network will enable systematic study of the effect of ERα on breast cancer. To investigate the regulatory network of ERα and discover novel modulators of ERα functions, we proposed an analytical method based on a linear regression model to identify translational modulators and their network relationships. In the network analysis, a group of specific modulator and target genes were selected according to the functionality of modulator and the ERα binding. Network formed from targets genes with ERα binding was called ERα genomic regulatory network; while network formed from targets genes without ERα binding was called ERα non-genomic regulatory network. Considering the active or repressive function of ERα, active or repressive function of a modulator, and agonist or antagonist effect of a modulator on ERα, the ERα/modulator/target relationships were categorized into 27 classes. Using the gene expression data and ERα Chip-seq data from the MCF-7 cell line, the ERα genomic/non-genomic regulatory networks were built by merging ERα/ modulator/target triplets (TF, M, T), where TF refers to the ERα, M refers to the modulator, and T refers to the target. Comparing these two networks, ERα non-genomic network has lower FDR than the genomic network. In order to validate these two networks, the same network analysis was performed in the gene expression data from the ZR-75.1 cell. The network overlap analysis between two cancer cells showed 1{\%} overlap for the ERα genomic regulatory network, but 4{\%} overlap for the non-genomic regulatory network. We proposed a novel approach to infer the ERα/modulator/target relationships, and construct the genomic/non-genomic regulatory networks in two cancer cells. We found that the non-genomic regulatory network is more reliable than the genomic regulatory network.",
author = "Wu, {Heng Yi} and Pengyue Zheng and Guanglong Jiang and Yunlong Liu and Nephew, {Kenneth P.} and Hui-ming Huang and Lang Li",
year = "2012",
language = "English (US)",
volume = "13 Suppl 6",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",

}

TY - JOUR

T1 - A modulator based regulatory network for ERα signaling pathway.

AU - Wu, Heng Yi

AU - Zheng, Pengyue

AU - Jiang, Guanglong

AU - Liu, Yunlong

AU - Nephew, Kenneth P.

AU - Huang, Hui-ming

AU - Li, Lang

PY - 2012

Y1 - 2012

N2 - Estrogens control multiple functions of hormone-responsive breast cancer cells. They regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. ERα requires distinct co-regulator or modulators for efficient transcriptional regulation, and they form a regulatory network. Knowing this regulatory network will enable systematic study of the effect of ERα on breast cancer. To investigate the regulatory network of ERα and discover novel modulators of ERα functions, we proposed an analytical method based on a linear regression model to identify translational modulators and their network relationships. In the network analysis, a group of specific modulator and target genes were selected according to the functionality of modulator and the ERα binding. Network formed from targets genes with ERα binding was called ERα genomic regulatory network; while network formed from targets genes without ERα binding was called ERα non-genomic regulatory network. Considering the active or repressive function of ERα, active or repressive function of a modulator, and agonist or antagonist effect of a modulator on ERα, the ERα/modulator/target relationships were categorized into 27 classes. Using the gene expression data and ERα Chip-seq data from the MCF-7 cell line, the ERα genomic/non-genomic regulatory networks were built by merging ERα/ modulator/target triplets (TF, M, T), where TF refers to the ERα, M refers to the modulator, and T refers to the target. Comparing these two networks, ERα non-genomic network has lower FDR than the genomic network. In order to validate these two networks, the same network analysis was performed in the gene expression data from the ZR-75.1 cell. The network overlap analysis between two cancer cells showed 1% overlap for the ERα genomic regulatory network, but 4% overlap for the non-genomic regulatory network. We proposed a novel approach to infer the ERα/modulator/target relationships, and construct the genomic/non-genomic regulatory networks in two cancer cells. We found that the non-genomic regulatory network is more reliable than the genomic regulatory network.

AB - Estrogens control multiple functions of hormone-responsive breast cancer cells. They regulate diverse physiological processes in various tissues through genomic and non-genomic mechanisms that result in activation or repression of gene expression. Transcription regulation upon estrogen stimulation is a critical biological process underlying the onset and progress of the majority of breast cancer. ERα requires distinct co-regulator or modulators for efficient transcriptional regulation, and they form a regulatory network. Knowing this regulatory network will enable systematic study of the effect of ERα on breast cancer. To investigate the regulatory network of ERα and discover novel modulators of ERα functions, we proposed an analytical method based on a linear regression model to identify translational modulators and their network relationships. In the network analysis, a group of specific modulator and target genes were selected according to the functionality of modulator and the ERα binding. Network formed from targets genes with ERα binding was called ERα genomic regulatory network; while network formed from targets genes without ERα binding was called ERα non-genomic regulatory network. Considering the active or repressive function of ERα, active or repressive function of a modulator, and agonist or antagonist effect of a modulator on ERα, the ERα/modulator/target relationships were categorized into 27 classes. Using the gene expression data and ERα Chip-seq data from the MCF-7 cell line, the ERα genomic/non-genomic regulatory networks were built by merging ERα/ modulator/target triplets (TF, M, T), where TF refers to the ERα, M refers to the modulator, and T refers to the target. Comparing these two networks, ERα non-genomic network has lower FDR than the genomic network. In order to validate these two networks, the same network analysis was performed in the gene expression data from the ZR-75.1 cell. The network overlap analysis between two cancer cells showed 1% overlap for the ERα genomic regulatory network, but 4% overlap for the non-genomic regulatory network. We proposed a novel approach to infer the ERα/modulator/target relationships, and construct the genomic/non-genomic regulatory networks in two cancer cells. We found that the non-genomic regulatory network is more reliable than the genomic regulatory network.

UR - http://www.scopus.com/inward/record.url?scp=84876079151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876079151&partnerID=8YFLogxK

M3 - Article

VL - 13 Suppl 6

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

M1 - S6

ER -